A prospective observational study to examine the relationship between quality of life and adverse events of first-line chemotherapy plus cetuximab in patients with KRAS wild-type unresectable metastatic colorectal cancer: QUACK Trial.
about
A prospective observational study to examine the relationship between quality of life and adverse events of first-line chemotherapy plus cetuximab in patients with KRAS wild-type unresectable metastatic colorectal cancer: QUACK Trial.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
A prospective observational st ...... olorectal cancer: QUACK Trial.
@en
A prospective observational st ...... olorectal cancer: QUACK Trial.
@nl
type
label
A prospective observational st ...... olorectal cancer: QUACK Trial.
@en
A prospective observational st ...... olorectal cancer: QUACK Trial.
@nl
prefLabel
A prospective observational st ...... olorectal cancer: QUACK Trial.
@en
A prospective observational st ...... olorectal cancer: QUACK Trial.
@nl
P2093
P2860
P921
P356
P1476
A prospective observational st ...... olorectal cancer: QUACK Trial.
@en
P2093
Akira Ooki
Atushi Sato
Hirofumi Fujii
Junichi Sakamoto
Kensei Yamaguchi
Masahiko Ando
P2860
P304
P356
10.1093/JJCO/HYU008
P577
2014-02-20T00:00:00Z